Korro Bio (KRRO) Cash from Investing Activities Growth (1y) (2019 - 2026)
Korro Bio (KRRO) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -198.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.35% |
| Dec 31, 2025 | 639.46% |
| Sep 30, 2025 | 160.39% |
| Jun 30, 2025 | 88.96% |
| Mar 31, 2025 | 684.23% |
| Dec 31, 2024 | -67.07% |
| Sep 30, 2024 | -1,768.17% |
| Jun 30, 2024 | -2,892.20% |
| Mar 31, 2024 | -136.23% |
| Dec 31, 2023 | -136.88% |
| Sep 30, 2023 | -94.29% |
| Jun 30, 2023 | -156.83% |
| Mar 31, 2023 | 222.31% |
| Dec 31, 2022 | 130.63% |
| Sep 30, 2022 | 257.05% |
| Jun 30, 2022 | 135.72% |
| Mar 31, 2022 | 51.69% |
| Dec 31, 2021 | -230.26% |
| Sep 30, 2021 | -727.34% |
| Jun 30, 2021 | -878.21% |